Nurix Therapeutics Q3 EPS $(0.65) Down From $(0.59) YoY, Sales $10.25M Up From $4.08M YoY

Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(0.65) per share. This is a 10.17 percent decrease over losses of $(0.59) per share from the same period last year. The company reported $10.25 million in

Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(0.65) per share. This is a 10.17 percent decrease over losses of $(0.59) per share from the same period last year. The company reported $10.25 million in sales this quarter. This is a 150.97 percent increase over sales of $4.08 million the same period last year.

Total
0
Shares
Related Posts

Beta is now closed - Our Newswire is Live! Receive 50% off Your First Month!

X